The DNA Synthesis Market was valued at USD 4.26 billion in 2025 and is estimated at USD 4.96 billion in 2026. It is projected to reach USD 17.24 billion by 2034, a CAGR of 16.85% from 2026 to 2034. Demand is fueled by the expansion of the biopharma industry and by wider use of AI and automation in synthesis workflows. DNA sequencing lets scientists read genetic code. DNA synthesis lets them write it, and that capability is becoming central to modern medicine and biotechnology.

What DNA Synthesis Delivers

DNA synthesis platforms build DNA sequences accurately, flexibly and efficiently. They serve pharmaceuticals, biotech, diagnostics, agriculture and research, and they enable gene editing, synthetic biology and the creation of new biomolecules. Advances in chemical and enzymatic methods, automation and quality control are raising speed, reliability and scalability across genomics, drug discovery and bioengineering.

Chemical vs. Enzymatic Synthesis

Chemical synthesis, based on phosphoramidite chemistry, is mature and cost-effective for standard oligonucleotides. It is widely used for PCR primers, probes and diagnostics. Its accuracy falls as sequences grow longer, and it generates chemical waste. Enzymatic synthesis uses enzymes under biological conditions. It promises higher fidelity for long sequences, a smaller environmental footprint and potentially faster workflows. It is still emerging, but it is gaining traction in gene synthesis, gene therapy development and vaccine research. In October 2025, a launch of an enzymatic platform offering sequence-perfect clonal DNA up to 50 kb showed how quickly this technology is advancing.

Key Growth Drivers

Biopharma growth is the strongest driver. Drug discovery, biologics and vaccine programs all rely on synthetic gene constructs and antibody libraries. India’s biopharma industry grew from USD 10 billion in 2014 to USD 165.7 billion in 2024, and it is expected to exceed USD 300 billion by 2030.

Genetic disease is the second driver. The World Health Organization estimates that about 10 in every 1,000 people are affected, which amounts to 70 to 80 million people worldwide. Gene therapy, diagnostics and personalized treatments depend on high-fidelity DNA. Oncology, rare disease and regenerative medicine are adding to that need.

Vaccine research is a third driver. DNA templates are the starting point for mRNA vaccine candidates, so fast synthesis helps researchers design and test sequences against emerging pathogens. Investment in pandemic preparedness is raising the use of synthetic DNA in vaccine and diagnostic development.

Automation and AI Open New Opportunities

AI is helping at several steps. It can analyze protocols, sequence complexity and reagent interactions, adjust temperature, timing and reagent flow in real time, and flag failures, degraded reagents or contamination to reduce waste. It also supports automated sequence design and high-throughput production. In October 2024, the CODA platform designed synthetic DNA components with high accuracy, which shows how AI can shorten research timelines.

Explore The Complete Comprehensive Report Here : https://www.polarismarketresearch.com/industry-analysis/dna-synthesis-market

Segment Insights

By type, oligonucleotide synthesis held the largest share, 68.9% in 2025. It is used heavily in PCR assays, next-generation sequencing and molecular diagnostics. Gene synthesis is expected to grow fastest as synthetic biology, genetic engineering and vaccine development demand larger, more complex DNA constructs.

By application, diagnostics led in 2025 with a 25.6% share, supported by DNA-based assays, biomarker discovery and infectious disease detection. Therapeutics is expected to grow fastest, at a CAGR of 17.2%, driven by gene therapies, biologics and precision medicine.

By end user, pharmaceutical and biotechnology companies held 56.2% in 2025. CROs and CDMOs are growing fastest as organizations outsource synthesis to cut costs, scale up and speed research. Outsourcing also gives startups and research institutions access to advanced tools.

Regional Outlook

North America led in 2025 with a 42.4% share, backed by strong biotech infrastructure, research funding and activity in gene therapy and CRISPR research. The U.S. market is projected to grow at 17.1%, supported by public genomics funding. Asia Pacific is expected to grow at 17.6% as India, China, Japan and South Korea expand genomics, vaccine and biotech capabilities. India is projected to grow at 17.5%, and Europe holds a substantial share thanks to programs such as Horizon Europe.

Competitive Landscape

Twist Bioscience, DNA Script and Molecular Assemblies are among the leading innovators. Other players include Integrated DNA Technologies, GenScript, Thermo Fisher Scientific, Eurofins, Camena Bioscience and Touchlight Genetics. Partnerships are shaping the field. In May 2025, Ginkgo Bioworks and Twist Bioscience extended their collaboration to three years. In March 2025, IDT and Elegen partnered to offer early access to a service for complex genes of 5 to 15 kb. In June 2026, IDT launched integrated oncology research workflows with Illumina software.

Challenges to Overcome

Long, complex sequences remain costly because they need extra synthesis and validation. Error rates rise with length, regulatory requirements differ by region, and scaling production while keeping quality consistent is difficult. The technology also demands specialized equipment and expertise. Progress in enzymatic methods, error correction and automation should ease these constraints over time.

DNA Synthesis Market growth through 2034 will be shaped by synthetic biology, personalized healthcare and the steady move toward faster, more accurate and more sustainable production methods. Companies that deliver longer sequences at lower cost, integrate AI and automation, and serve outsourcing partners will be well placed to benefit. As biotechnology reaches into healthcare, agriculture and industrial production, synthetic DNA is set to remain a foundational technology.

More Trending Latest Reports By Polaris Market Research:

Unified Communications Market

Automated Guided Vehicle (Agv) Market

Genomics In Cancer Care Market

Singapore, Malaysia, and China Corporate Secretarial Services Market

Automated Guided Vehicle (Agv) Market

Obesity Treatment Market

Antiscalants Market

3D Motion Capture System Market

Benign Prostatic Hyperplasia Surgical Treatment Market